Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Postmeal Optogenetic Inhibition of Dorsal or Ventral Hippocampal Pyramidal Neurons Increases Future Intake.

Hannapel R, Ramesh J, Ross A, LaLumiere RT, Roseberry AG, Parent MB.

eNeuro. 2019 Jan 28;6(1). pii: ENEURO.0457-18.2018. doi: 10.1523/ENEURO.0457-18.2018. eCollection 2019 Jan-Feb.

2.

Neuropeptide-Y alters VTA dopamine neuron activity through both pre- and postsynaptic mechanisms.

West KS, Roseberry AG.

J Neurophysiol. 2017 Jul 1;118(1):625-633. doi: 10.1152/jn.00879.2016. Epub 2017 May 3.

3.

Altered sucrose self-administration following injection of melanocortin receptor agonists and antagonists into the ventral tegmental area.

Shanmugarajah L, Dunigan AI, Frantz KJ, Roseberry AG.

Psychopharmacology (Berl). 2017 Jun;234(11):1683-1692. doi: 10.1007/s00213-017-4570-4. Epub 2017 Feb 27.

PMID:
28243712
4.

Neurotensin inhibits both dopamine- and GABA-mediated inhibition of ventral tegmental area dopamine neurons.

Stuhrman K, Roseberry AG.

J Neurophysiol. 2015 Sep;114(3):1734-45. doi: 10.1152/jn.00279.2015. Epub 2015 Jul 15.

5.

Regulation of the mesocorticolimbic and mesostriatal dopamine systems by α-melanocyte stimulating hormone and agouti-related protein.

Roseberry AG, Stuhrman K, Dunigan AI.

Neurosci Biobehav Rev. 2015 Sep;56:15-25. doi: 10.1016/j.neubiorev.2015.06.020. Epub 2015 Jun 24. Review.

PMID:
26116876
6.

Acute fasting increases somatodendritic dopamine release in the ventral tegmental area.

Roseberry AG.

J Neurophysiol. 2015 Aug;114(2):1072-82. doi: 10.1152/jn.01008.2014. Epub 2015 Jun 17.

7.

Decreased consumption of rewarding sucrose solutions after injection of melanocortins into the ventral tegmental area of rats.

Yen HH, Roseberry AG.

Psychopharmacology (Berl). 2015 Jan;232(1):285-94. doi: 10.1007/s00213-014-3663-6. Epub 2014 Jul 3.

PMID:
24985892
8.

Altered feeding and body weight following melanocortin administration to the ventral tegmental area in adult rats.

Roseberry AG.

Psychopharmacology (Berl). 2013 Mar;226(1):25-34. doi: 10.1007/s00213-012-2879-6. Epub 2012 Sep 26.

PMID:
23010797
9.

Decreased vesicular somatodendritic dopamine stores in leptin-deficient mice.

Roseberry AG, Painter T, Mark GP, Williams JT.

J Neurosci. 2007 Jun 27;27(26):7021-7.

10.

Rapid rewiring of arcuate nucleus feeding circuits by leptin.

Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, Friedman JM, Horvath TL.

Science. 2004 Apr 2;304(5667):110-5.

11.
12.

Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter.

Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, Montez JM, Friedman JM, Elmquist JK.

J Neurosci. 2003 Aug 6;23(18):7143-54.

13.

Agonist-dependent delivery of M(2) muscarinic acetylcholine receptors to the cell surface after pertussis toxin treatment.

Roseberry AG, Bünemann M, Elavunkal J, Hosey MM.

Mol Pharmacol. 2001 May;59(5):1256-68.

PMID:
11306711
15.

Trafficking of M(2) muscarinic acetylcholine receptors.

Roseberry AG, Hosey MM.

J Biol Chem. 1999 Nov 19;274(47):33671-6.

16.

Desensitization of G-protein-coupled receptors in the cardiovascular system.

Bünemann M, Lee KB, Pals-Rylaarsdam R, Roseberry AG, Hosey MM.

Annu Rev Physiol. 1999;61:169-92. Review.

PMID:
10099686
17.

Molecular events associated with the regulation of signaling by M2 muscarinic receptors.

Hosey MM, Pals-Rylaarsdam R, Lee KB, Roseberry AG, Benovic JL, Gurevich VV, Bünemann M.

Life Sci. 1999;64(6-7):363-8.

PMID:
10069497

Supplemental Content

Loading ...
Support Center